Home › › Consult Details

MnM’s client, a leading medical device and diagnostics company, was losing its market share in the cervical cancer test kits market in U.S. and wanted to understand the dynamics of these kits in U.S. in terms of value and volume (number of tests and kits sold per year). The project focused on segments by test kits (Pap and HPV) and End-users (Hospitals, Laboratories, Physicians). The project also aimed at estimating the number of Pap tests and HPV tests and analyzing their trends.

1. Methodology Adopted by MnM :

Both, top-down and bottom-up approaches were used to derive the data. MnM utilized authentic secondary sources (government websites, associations and groups, annual reports of companies, SEC filings, corporate presentations) along with MnM Repository to gain insights, both quantitative and qualitative, into the market. MnM then conducted multi-level, qualitative & quantitative study with a constructed sample of mid to senior level management executives and industry professionals to understand key parameters influencing the market. At every level the estimates were further verified with industry experts.

2. Actual Solution Provided:

• Market sizing and forecast for cervical cancer screening test kits and procedures
• Guidelines for regulations associated with cervical cancer in U.S.
• Profile of key companies and competitive landscape
• Strategic insights for market penetration and positioning

Value Delivered:

The client could identify the market potential and challenges in the market. They were also able to identify the reasons for dropping sales which aided them to take appropriate steps to improve their sales.